Surgical outcomes for papillary thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at patients with papillary thyroid cancer who had surgery at Sohag University Hospitals. It aims to understand their outcomes and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with papillary thyroid cancer (the most common type of thyroid cancer).
- The diagnosis was confirmed by a biopsy (tissue sample).
- You have not had any previous thyroid surgery before coming to this hospital.
- Your medical records must be complete enough for the researchers to use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people who have had thyroid surgery to learn more about their health over time. It may help improve care for future patients with thyroid conditions.
This study looks at how thyroid cancer—or thyroid tumors that may be cancer—affect your quality of life before and after surgery. It may help doctors understand what patients experience and how treatment planning could be better.
This study looks at how you feel after thyroid surgery for cancer. It tests whether adding Chinese medicine treatments can help with symptoms like pain or fatigue during recovery.
This study looks at how iodine levels in your body relate to papillary thyroid cancer. It aims to understand the condition better, which may help with future treatment and prevention.
This study tests a less invasive surgery for early-stage thyroid cancer that has not spread to lymph nodes or other parts of the body. The goal is to see if it works well and helps patients recover with less scarring.
This study looks at thyroid cancer and how standard treatments and other health details relate to outcomes. You might be eligible if you have thyroid cancer and can participate by giving informed consent.
Hear when a new Papillary Thyroid Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.